809 A bispecific antibody targeting CCR8 & CTLA-4: Potent anti-tumor efficacy with better safety by preferentially eliminating tumor-infiltrating regulatory T cells

• Chao Wang,
• Yi Luo,
• Tianhang Zhai,
• Weifeng Huang,
• Shuang Dai,
• Shaogang Peng,
• Andy Tsun,
• Xiaoniu Miao,
• Liandi Chen

Affiliations

Chao Wang

Department of Pathology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China

Yi Luo

1Biotheus Inc., Zhuhai, China

Tianhang Zhai

2Biotheus (Suzhou) Co., Ltd., Suzhou, China

Weifeng Huang

2Biotheus (Suzhou) Co., Ltd., Suzhou, China

Shuang Dai

2Biotheus (Suzhou) Co., Ltd., Suzhou, China

Shaogang Peng

2Biotheus (Suzhou) Co., Ltd., Suzhou, China

Andy Tsun

1Biotheus Inc., Zhuhai, China

Xiaoniu Miao

1Biotheus Inc., Zhuhai, China

Liandi Chen

1Biotheus Inc., Zhuhai, China